2026 CERTIFIED TRADE MISSION TO
Abu Dhabi, UAE
Join us on October 7, 2026
Round table meetings with U.S. Healthcare Funds/Companies
Register Now
TRADE MISSIONS
U.S. Funds/ Companies
Empiriko
Company
Empiriko is a biotech company focused on developing targeted radioligand therapies and antibody drug conjugates for cancer and next generation point-of-care diagnostics.
Genius Clinic
Company
GENIUS is a next-level healthcare AI Rx infrastructure—a sophisticated, fully interoperable data ingestion, transformation, and management system. GENIUS is focused on helping patients, physicians, payers, and pharma create true value from their data. Built with security, speed, and accuracy, GENIUS enables genuine insights - for healthcare providers, their network, payers, and pharma - during engagements. Existing approaches use legacy ML and rules-based engines which have limitations in reliability and speed, all of which affect patient care. Believe it or not, providers and payers are still using e-faxes to transmit PAs.
GuideAI Health
Company
GuideAI Health was founded by interventional radiologists with a mission to improve early detection and diagnosis of life-threatening chronic vascular diseases. Our advanced AI/ML models rapidly interpret and translate mass volumes of imaging data, providing data-driven solutions designed to optimize radiologist efficiency, elevate disease recognition and management, and guide patients to appropriate care.
Mitochon Pharmaceuticals, Inc.
Company
Mitochon Pharmaceuticals is a clinically staged biotech that is focused on developing drugs that target the mitochondria for a host of serious diseases with significant unmet medical needs. Our development programs are primarily focused on neurodegenerative diseases including: Huntington’s Disease, Multiple Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s, Parkinson and Traumatic Brain Injury (TBI). By correcting mitochondrial physiology, we aim at opening the way for a broad range of disease modifying therapies. Our platform is based upon mitochondrial enhancers that specifically target the mitochondria as an oral once-per-day brain penetrating therapy that wakes up compensatory pathways pro-survival (MOA: https://www.mitochonpharma.com/mechanism-of-action/).
Noxy Health Products
Company
Noxy Health Products is a healthcare company driven to developing innovative medicines that harness the natural restorative power of nitric oxide to heal chronic wounds.
Retro BioSciences
Company
Retro develops therapies for diseases driven by the biology of aging. We focus on cellular reprogramming and autophagy to rejuvenate cell and tissue function with the ultimate aim of adding 10 years to healthy human lifespan.
SignPath Pharma
Company
SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a serious and common side effect of many drugs, and heart muscle damage caused by chemotherapy.
Tosk Inc.
Company
Tosk Inc. is a biopharmaceutical company dedicated to improving outcomes for cancer patients by developing new drugs to improve the safety and efficacy of existing therapies and to block the activity of cancer genes.
DDS Founders Fund
Venture Capital
DDS Founders Fund is a legacy investment group that has over 30 years of experience in the industry, leveraging goodwill in the industry to invest with preferred terms and positioning, and exorbitant deal flow within healthcare focused on oral health. DDS Founders Fund has positioned itself as the most sought-after VC in the dental industry, largely because of its fund managers' legendary track record of working with founders in meaningful ways that deliver existential impact.
GROWQ360
Venture Capital
Mission: To connect healthcare innovation, investment, and adoption - guiding founders from ideation to commercialization through an inside-out approach. Vision: A world where healthcare breakthroughs complete the full journey - from idea to investment to implementation - without dying in the gaps between. Purpose: To transform healthcare by asking the right questions - and being the fundamental force that connects innovation, investment, and adoption. Because each one alone is incomplete. Connected, they change healthcare.
Khai Ventures
Venture Capital
KHAI Ventures originates, supports, and invests in a collaborative, purpose-built portfolio of companies. Through shared expertise, technology, channels, and resources, we help healthcare AI founders address these challenges and build scalable, impactful solutions. Our portfolio is focused on three core themes: clinically actionable and commercially relevant predictive models, new care delivery models that leverage data to improve efficiency and quality, and innovative approaches to monitoring patient health and wellness over time.
Obsidian Capital Partners
Venture Capital
An institutional M&A and growth capital platform taking principal positions in infrastructure and industrial platform companies. We structure capital. We build management capacity. We stay.
Patient Partner Capital
Venture Capital
VC dedicated to women’s health, bridging science with patient reality to de-risk innovation and accelerate impact. We invest in early-stage companies addressing high-impact, unmet needs in women’s health, bridging patient insights and science from day one to de-risk development.
RCP Venture Capital
Venture Capital
RCP Venture Capital is Cambridge, Massachusetts-based emerging venture capital firm funding seeking to serve as a strategic partner beyond the deployment of capital. RCP Venture Capital prefers to provide smaller incremental funding to help portfolio companies achieve near-term clinical or commercial goals serving to bridge the gap between large private market funding and early phase company risk to harness opportunity that might otherwise not be realized. The firm collaborates closely with larger venture capital and private equity partners to provide advisory opportunities and enable the potential for follow-on financing.
Ultimate Manager LLC
Venture Capital
The Ultimate Human Wellness was founded by Human Biologist and longevity expert Gary Brecka to help people understand and optimize their biology. With over 20 years of experience analyzing human biomarkers and human performance data, Gary built his career predicting health outcomes with remarkable accuracy. His mission was never to forecast lifespans. It was to extend them and improve quality of life. The Ultimate Human Wellness brings lab grade genetic insights into everyday wellness, decoding how your genetics influence energy, mood, recovery, metabolism, and longevity. By translating complex biological data into clear, actionable guidance, TUHW empowers individuals to stop guessing and start optimizing.
EVENT CO-CHAIRS
VIvien Tsui
Director, Tycheon Capital
Abbas Hashmi
Principal, Saudi Family Holdings | Program Leader, Columbia Business School, Family Enterprises and Wealth
Dr. Tahir Hussain
Chief Executive Officer, Canadian Specialist Hospital Group
Matthew Francis
Managing Partner, E11 Partners
Serhat Yalcinkaya
Global Pharma Executive | Former Country Manager, Pfizer Gulf Cluster
U.S. DEPARTMENT OF COMMERCE
Brian N. Beams
Director, Global Financial Services Team, U.S. Commercial Service
Christelle Rezk
Commercial Specialist, U.S. Consulate General Dubai
Maya Najm
Senior Commercial Specialist, U.S. Embassy Abu Dhabi
Vandana Nair
Commercial Specialist, U.S. Consulate General Dubai
TESTIMONIAL
“I thought the Trade Mission was one of the most unique fundraising assets I’ve ever seen. The ability to have 50+ warm leads provided over the course of 1 day is phenomenal. It would have been impossible for our fund to have done anything like this ourselves and I doubt any financial service organizations could have provided a stronger group. I would highly recommend the Trade Mission, not just because of the quantity of potential investors but the quality of investors.”
– Maxx Bricklin, Principal, Bold Capital Partners, LP
U.S. Department of Commerce Certified Trade Mission:
Introductions to Leading U.S. Healthcare Funds/Companies
Register Now
To learn more please schedule a call with Irwin Katsof, Managing Director of Trade Missions
Schedule a Call